Emn Trial Office S.r.l. Impresa Sociale

Clinical activity is centered on multiple myeloma across newly diagnosed, relapsed, and high-risk settings, including patients with extramedullary disease and those eligible or ineligible for autologous stem cell transplantation.

• Newly diagnosed multiple myeloma
• Relapsed multiple myeloma
• Transplant-eligible and transplant-ineligible disease
• Extramedullary involvement

The research portfolio also includes younger patients with transplant-related treatment pathways and maintenance-focused approaches after initial disease control.